Stay updated on Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial
Sign up to get notified when there's something new on the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page.

Latest updates to the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to indicate that it is now completed, while previously it was noted as active but not recruiting.SummaryDifference0.7%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page.